GKOS

85.38

2.59% 2.285

Handel nachbörslich: 85.32 -0.055 -0.06%

Glaukos Corporation (GKOS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$83.09

Offen:

$83.22

24-Stunden-Volumen:

1.04M

Relative Volume:

1.14

Marktkapitalisierung:

$4.90B

Einnahmen:

$360.35M

Nettoeinkommen (Verlust:

$-149.57M

KGV:

-28.84

EPS:

-2.96

Netto-Cashflow:

$-81.27M

1W Leistung:

+1.37%

1M Leistung:

+3.00%

6M Leistung:

-8.26%

1J Leistung:

-34.45%

1-Tages-Spanne:

$82.46

$86.74

1-Wochen-Bereich:

$82.19

$87.83

52-Wochen-Spanne:

$77.10

$163.71

Glaukos Corporation Stock (GKOS) Company Profile

Firmenname

Glaukos Corporation

Sektor

Healthcare (1146)

Branche

Medical Devices (146)

Telefon

949-367-9600

Adresse

1 GLAUKOS WAY, ALISO VIEJO, CA

Mitarbeiter

995

Twitter

@GlaukosCorp

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

GKOS's Discussions on Twitter

Vergleichen Sie GKOS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GKOS Glaukos Corporation	85.38	4.77B	360.35M	-149.57M	-81.27M	-2.96
ABT Abbott Laboratories	133.26	228.66B	43.11B	13.94B	6.78B	7.9963
BSX Boston Scientific Corp	96.24	140.69B	18.49B	2.50B	3.49B	1.6801
SYK Stryker Corp	369.88	139.51B	23.82B	2.92B	4.02B	7.5574
MDT Medtronic Plc	96.53	122.60B	34.20B	4.69B	5.30B	3.6218
EW Edwards Lifesciences Corp	73.35	42.83B	5.69B	1.41B	577.90M	6.9828

Glaukos Corporation Stock (GKOS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-01	Eingeleitet	Goldman	Buy
2025-05-01	Herabstufung	Wells Fargo	Overweight → Equal Weight
2025-02-19	Hochstufung	Mizuho	Neutral → Outperform
2024-12-11	Hochstufung	Citigroup	Neutral → Buy
2024-12-06	Eingeleitet	UBS	Buy
2024-12-02	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2024-07-10	Herabstufung	Citigroup	Buy → Neutral
2024-05-06	Hochstufung	Jefferies	Hold → Buy
2023-12-21	Hochstufung	JP Morgan	Neutral → Overweight
2023-12-04	Eingeleitet	Morgan Stanley	Equal-Weight
2023-11-28	Eingeleitet	Truist	Buy
2023-11-08	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-06-07	Hochstufung	Piper Sandler	Neutral → Overweight
2022-12-22	Eingeleitet	Mizuho	Neutral
2022-12-19	Hochstufung	JP Morgan	Underweight → Neutral
2022-12-12	Hochstufung	Citigroup	Neutral → Buy
2022-10-14	Fortgesetzt	Stephens	Overweight
2022-10-04	Eingeleitet	Needham	Buy
2022-07-12	Hochstufung	Stifel	Hold → Buy
2022-02-03	Hochstufung	William Blair	Mkt Perform → Outperform
2022-01-19	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-01-18	Hochstufung	BTIG Research	Neutral → Buy
2021-11-03	Hochstufung	Stephens	Equal-Weight → Overweight
2021-07-26	Herabstufung	Stephens	Overweight → Equal-Weight
2021-07-20	Herabstufung	Wells Fargo	Equal Weight → Underweight
2021-07-14	Herabstufung	Oppenheimer	Outperform → Perform
2021-07-14	Herabstufung	William Blair	Outperform → Mkt Perform
2021-04-08	Hochstufung	Oppenheimer	Perform → Outperform
2021-01-29	Herabstufung	Piper Sandler	Overweight → Neutral
2020-12-16	Hochstufung	Citigroup	Sell → Neutral
2020-12-09	Eingeleitet	Oppenheimer	Perform
2020-11-17	Hochstufung	Wells Fargo	Underweight → Equal Weight
2020-10-08	Herabstufung	JP Morgan	Neutral → Underweight
2020-06-15	Eingeleitet	Jefferies	Hold
2020-03-05	Eingeleitet	Citigroup	Sell
2020-02-28	Herabstufung	JP Morgan	Overweight → Neutral
2020-01-06	Hochstufung	Berenberg	Hold → Buy
2019-12-12	Herabstufung	Wells Fargo	Outperform → Underperform
2019-09-30	Herabstufung	BofA/Merrill	Buy → Underperform
2019-03-08	Eingeleitet	BTIG Research	Neutral
2018-08-30	Eingeleitet	Berenberg	Hold
2018-08-29	Hochstufung	JP Morgan	Neutral → Overweight
2018-08-03	Bestätigt	Stifel	Hold
2018-06-21	Herabstufung	JP Morgan	Overweight → Neutral
2018-04-13	Herabstufung	Stifel	Buy → Hold
2018-03-01	Bestätigt	Cantor Fitzgerald	Buy
2017-03-02	Bestätigt	Cantor Fitzgerald	Overweight
2017-01-06	Hochstufung	Stifel	Hold → Buy
2016-10-27	Eingeleitet	Wells Fargo	Outperform

Alle ansehen

Glaukos Corporation Aktie (GKOS) Neueste Nachrichten

11:47 AM

How cyclical is Glaukos Corporation (6GJ) stock compared to rivalsJuly 2025 Closing Moves & Technical Analysis for Trade Confirmation - newser.com

11:47 AM

10:04 AM

Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting - PharmiWeb.com

10:04 AM

05:32 AM

Will Glaukos Corporation stock outperform energy sector in 2025July 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - newser.com

05:32 AM

05:08 AM

Combining machine learning predictions for Glaukos CorporationPortfolio Update Report & Proven Capital Preservation Methods - newser.com

05:08 AM

02:25 AM

How to build a custom watchlist for Glaukos Corporation2025 Market Outlook & Real-Time Buy Zone Alerts - newser.com

02:25 AM

02:21 AM

What analysts say about Glaukos Corporation stockStock Price Divergence & Small Budget Trading Plans - earlytimes.in

02:21 AM

Oct 13, 2025

Does Glaukos Corporation qualify in momentum factor screening2025 Pullback Review & Expert Approved Momentum Ideas - newser.com

Oct 13, 2025

What to do if you’re stuck in Glaukos Corporation2025 Geopolitical Influence & Proven Capital Preservation Methods - newser.com

Oct 13, 2025

Can Glaukos Corporation hit a new high this monthGold Moves & Safe Entry Zone Tips - newser.com

Oct 13, 2025

Will Glaukos Corporation stock attract long term capital inflowsQuarterly Profit Summary & Detailed Earnings Play Strategies - newser.com

Oct 13, 2025

Glaukos (GKOS) Analyst Rating Update: BTIG Lowers Price Target | - GuruFocus

Oct 13, 2025

Is Glaukos Corporation stock dividend yield sustainable2025 Valuation Update & Daily Chart Pattern Signals - newser.com

Oct 13, 2025

Oct 12, 2025

How to read the order book for Glaukos CorporationWeekly Profit Summary & Community Verified Watchlist Alerts - newser.com

Oct 12, 2025

Using Python tools to backtest Glaukos Corporation strategiesJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com

Oct 12, 2025

Glaukos gains as Goldman Sachs initiates at Buy on valuation - MSN

Oct 12, 2025

Oct 11, 2025

InvestingPro’s January Glaukos warning preceded 47% stock drop By Investing.com - Investing.com Australia

Oct 11, 2025

Oct 10, 2025

Glaukos Corporation stock trend outlook and recovery pathQuarterly Trade Review & Reliable Entry Point Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

How hedge fund analytics apply to Glaukos Corporation stockPrice Action & Advanced Swing Trade Entry Plans - newser.com

Oct 09, 2025

Glaukos Corporation (NYSE:GKOS) Shares Could Be 46% Below Their Intrinsic Value Estimate - 富途牛牛

Oct 09, 2025

Analyzing net buyer seller activity in Glaukos Corporation2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - newser.com

Oct 09, 2025

Glaukos' (GKOS) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 08, 2025

Glaukos breaks ground on high-tech facility in Alabama, eyes 150 jobs - Alabama News Center

Oct 08, 2025

Stifel maintains Buy rating on Glaukos stock ahead of Epioxa PDUFA date - Investing.com Nigeria

Oct 08, 2025

Stifel maintains Buy rating on Glaukos stock ahead of Epioxa PDUFA date By Investing.com - Investing.com South Africa

Oct 08, 2025

Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29 - The Globe and Mail

Oct 08, 2025

Oct 07, 2025

Glaukos Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 07, 2025

Citigroup Issues Pessimistic Forecast for Glaukos (NYSE:GKOS) Stock Price - MarketBeat

Oct 07, 2025

GKOS: Citigroup Lowers Price Target, Maintains Buy Rating | GKOS Stock News - GuruFocus

Oct 07, 2025

Glaukos breaks ground on high-tech facility in Huntsville, eyes 150 jobs - Alabama Department of Commerce

Oct 07, 2025

Oct 06, 2025

Volume spikes in Glaukos Corporation stock – what they meanQuarterly Portfolio Summary & High Accuracy Buy Signal Tips - newser.com

Oct 06, 2025